What sectors does Golden Eagle focus on?

Golden Eagle focuses on Biotech, Crypto & Web3, Healthtech.

Where is Golden Eagle located?

Golden Eagle is headquartered in Boston, US.

Golden Eagle

Venture capitalActively deploying

Boston · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Golden Eagle Partners is a specialist advisory and investment banking firm focused on the cannabis (THC+, industrial and molecular hemp), psychopharmacology, and life science sectors. Rather than acting as generalists, GEP concentrates on these related industries, drawing on operational experience in process development, manufacturing, business development, real estate, and finance. The firm advises clients on a wide range of transaction types including mergers, acquisitions, reverse mergers, equity and debt financings, licensing, joint ventures, co-development, IPOs, private placements, and structured PIPEs, aiming to match deals to clients' near- and long-term goals.

Invests inBiotech Crypto & Web3 HealthtechBostonGlobalUnited States

Source: firm website, verified Aug 3, 2026.

Boston, US

Instruments

Equity · Debt

Founded

2012

Team · 7 people

from the firm's website

Matt Daugherty· Director· Grand Rapids Metropolitan Areain

Director at Golden Eagle Partners who sources, manages and closes equity and debt transactions, with over 18 years in capital markets and prior roles at Somerset Capital, AR2 Capital, Standard & Poor's and Oppenheimer. Holds FINRA Series 7, 63 and 65 licenses.

Matthew Daugherty· Director· Chico, California, United Statesin

Director focused on sourcing, managing and closing equity and debt transactions. Brings over 18 years of capital markets experience with expertise in due diligence and analytics across alternative investments. Previously worked at Somerset Capital, AR2 Capital, Alpha Strategies, and held fixed income trading roles at Continental Investor Services and First Southwest Company.

David Traylor· Senior Managing Director· Charlotte, North Carolina, United Statesin

Founder of Golden Eagle Partners (2012), with a background in life-science investment banking and biotech operations who shifted focus to the cannabis sector. Holds B.A. degrees and an MBA from the University of Colorado, Boulder and holds FINRA Series 7, 63 and 66 licenses.

Graeme Martin· Consultant / Advisor· London, UK / San Francisco Bay Areain

Pharmacologist with a Ph.D. from University College London and an extensive pharma R&D career, later leading Takeda's venture group and founding HatchBox Bioconsulting to support early-stage life science innovation.

James (Jamie) W. Baumgartner· Advisor· Silverthorne, Colorado, United Statesin

Advisor to Golden Eagle Partners and Chief Research Officer at Panacea Life Sciences, with a Ph.D. in biochemistry and a long career leading biotech and pharmaceutical research organizations.

James W. Baumgartner

Advisor to Golden Eagle Partners and currently Chief Research Officer at Panacea Life Sciences. Joined Panacea in 2017 as President and CEO, leading its growth from 4 employees to a GMP-certified vertically integrated cannabinoid company with 30+ staff. Holds Ph.D. in biochemistry and has led research teams at major pharmaceutical companies including Amgen and Zymogenetics, with 11 patents to his name.

Ron Kammerzell· Consultant / Advisor· Coloradoin

Independent consultant specializing in regulatory policy and government affairs, recognized as an expert in marijuana regulatory policy after over 25 years at the Colorado Department of Revenue.

Frequently asked questions

What sectors does Golden Eagle focus on?: Golden Eagle focuses on Biotech, Crypto & Web3, Healthtech.
Where is Golden Eagle located?: Golden Eagle is headquartered in Boston, US.

Media · Podcasts & interviews

featuring the team

E110 - David Traylor and Golden Eagle Partners (Re-Hash)

ReeferMEDness the Podcast · David Traylor

CBE22: David Traylor - Golden Eagle Partners

World Class Business Leaders · David Traylor

CANNABIS STRATEGIC TRANSACTIONAL OPTIONS | David Traylor (Senior MD, Golden Eagle Partners)

The Cannabis Review Show · David Traylor

David Traylor, Golden Eagle Partners, Senior Managing Director - Investment Banking

CanXpo - Cannabis Expo · David Traylor

Similar investors

Andreessen Horowitz

Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.

$500K – $50M

Kreos Capital

Kreos Capital is a growth debt provider founded in 1998, financing high-growth technology and healthcare companies across Europe and Israel. It was acquired by BlackRock in August 2023 and operates its Growth Debt strategy within BlackRock's Private Markets platform.

Morningside Group

Version One Ventures

Version One Ventures is an early-stage venture firm that backs mission-driven founders building technology companies with generational potential, often committing from day one before a category is clear.

$250K – $500K

Bold Capital Partners

BOLD Capital Partners is a venture firm backing entrepreneurs across a range of technical and scientific domains, with a dedicated BOLD Longevity Growth practice.